DevelopmentPipelineContact
VECT/S
Bio

Turning Compute into Drugs.

Development

AI across the entire drug development stack: from discovery through approval.

Vectis Bio has rethought the entire drug development stack, from preclinical through approval, turning compute into drugs.

Preclinical

AI-native development from discovery through preclinical.

Clinical

Evidence-focused clinical development that supports meaningful program decisions.

Regulatory

Clear, strategic development packages to support regulatory engagement through submission.

Pipeline

Therapeutic pipeline

Clinical
VCT-101
Tendinopathy
Active
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Clinical
VCT-102
Carpal Tunnel Syndrome
Active
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
In-silico
VCT-201
POTS
Active
Discovery
Preclinical
Phase 1
Phase 2
Phase 3